969 North Mason, Suite 240

St. Louis, MO 63141

Call The CRC

(314) 514-8509

969 North Mason, Suite 240

St. Louis, MO 63141

Call The CRC

(314) 514-8509

Current Study Opportunities at The CRC

Studies at CRC can change frequently.  For the most up to date information of current enrolling studies please fill out the form on the right or call 314-514-8509 ext 12 to see if you qualify for a study. Studies listed were updated on 1-12-22.

Study #1: Investigational Asthma study comparing an approved combination inhaler versus an investigational combination inhaler.

Brief description of study

This study requires 8 visits over approximately 24 weeks. Morning appointments required. Subjects must have asthma for at least 6 months and currently treating with medium to high dose inhaled steroids for at least 8 weeks. Patients must be 12-80 years of age, non-smoker and BMI (Body Mass Index) of less than 40. Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Study #2: Investigational asthma study comparing once daily oral medication as add-on therapy to placebo.

Brief description of study

This study requires 4 visits over approximately 7 weeks. 2 of the visits are overnight in our clinic. Subjects must be on a medium to high daily dose of inhaled steroids or any daily dose of combination inhaled steroids and LABA for at least 3 months. Subjects will stay on their daily inhaled asthma therapy throughout the study. Subjects must be between 18-55 years of age, non-smoker, with a BMI (body mass index) of less than 32. Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Study #3: COPD Research Study for those using rescue inhaler as needed or daily maintenance therapy.

Brief description of study

This study requires 5 visits over approximately 7 weeks. Subjects must have physician diagnosed COPD and currently treating with rescue inhalers as needed or a stable daily dose of maintenance medication for at least the past month. Subjects will be over 40 years of age and be a current smoker or have a former smoke history of 10 or more pack years.  Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Study #4: RSV Vaccine Research Study for those 60 years of age or older comparing recombinant RSV vaccine to placebo.

Brief description of study

This study requires 1 in-person visit to screen and receive vaccination; then e-diary completion and a monthly phone call for 12 months following vaccination; additional in-person visit(s) would be required if subject experiences RSV symptoms during the 12 months following vaccination. Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Study #5: Research Study for Chronic Hives and/or Chronic Urticaria

Brief description of study

This study requires 13 visits over approximately 60 weeks. Visits include study elated lab work, ECG’s, and physical exams. This is an investigational twice daily oral medication for the treatment of uncontrolled hives.  Subjects must have chronic hives diagnosed for at least 6 months and suffer with these hives despite using an oral long-acting antihistamine. These hives must be chronic and spontaneous and not have a known cause. Subjects must be over 18 years of age. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Study #6: Research Study for Adults with Asthma comparing an approved combination inhaler to an investigational combination inhaler and to placebo.

Brief description of study

This study requires 5 visits and 4 phone calls over approximately 10 weeks. To qualify you must be between 18-70 years of age and have asthma for at least 6 months. Subjects may be on rescue medication as needed or be stable on their daily maintenance therapy for at least 4 weeks. Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Study #7: An investigational research study of an inhaled triple therapy versus placebo for people with moderate to severe asthma.

Brief description of study

This investigational research study has 15 visits. Subjects must be currently using medium to high daily dose inhaled maintenance medication. This study does have a BMI (Body Mass Index) restriction of less than 40. Must be 12-80 years of age and non-smoker with little to no previous smoke history. Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Study #8: COPD Research Study comparing Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.investigational inhaled triple therapy to investigational inhaled double therapy.

Brief description of study

This study requires 12 visits over approximately 55 weeks. A chest x-ray is required within 6 months of or at screening. Subjects must be at least 40 years of age with physician diagnosed COPD and be treating with a daily inhaled maintenance therapy with a stable dose for at least 3 months. Subjects must have experienced a COPD flare requiring treatment with oral steroids or antibiotics or have been hospitalized within the past 12 months.  Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Study #9: Moderate to Severe Asthma Research Study for those currently using medium to high dose controller medication for at least 3 months and have required an oral steroid for a flare in breathing at least once in the last 12 months.

Brief description of study

This investigational research study is enrolling moderate to severe asthmatics. To qualify you must be on inhaled maintenance medications and have required oral steroids at least once in the last year, for asthma. The study consists of 17 visits over approximately 7-8 months. Subjects will remain on current asthma controllers. The study medication is an injectable investigational medication and will be given every 2 weeks. Pulmonary function test will be performed. Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

Contact CRC
By acknowledging or signing the agreement, the customer is authorizing The Clinical Research Center to periodically send text message updates about current or future studies that may be of interest. The Clinical Research Center will send occasional texts pertaining to studies that may be of interest to you or studies that you are enrolled in. You can opt-out at any time. Text and data rates may apply. Privacy Policy.